Home
Browse
Search
Statistics
About
Usage
PMID: 12727866
Kogan I, Ramjeesingh M, Li C, Kidd JF, Wang Y, Leslie EM, Cole SP, Bear CE
CFTR directly mediates nucleotide-regulated glutathione flux.
EMBO J. 2003 May 1;22(9):1981-9., 2003-05-01
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
2
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:2:116
status:
NEW
view ABCC7 p.Arg347Asp details
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:2:165
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:2:155
status:
NEW
view ABCC7 p.Lys464Ala details
We show that CFTR-expressing membrane vesicles mediate nucleotide-activated GSH ¯ux, which is disrupted in the
R347D
pore mutant, and in the Walker A
K464A
and
K1250A
mutants.
Login to comment
7
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:7:48
status:
NEW
view ABCC7 p.Arg347Asp details
Keywords: CFTR/glutathione/puri®ed protein/
R347D
pore mutant/Walker A mutants Introduction Cystic ®brosis (CF) is a lethal autosomal recessive disease caused by mutations within the cystic ®brosis transmembrane conductance regulator (CFTR) gene (Boat et al., 1989).
Login to comment
63
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:63:35
status:
NEW
view ABCC7 p.Arg347Asp details
As seen in Figure 3A (insert), the
R347D
variant was expressed well in Sf9 membranes.
Login to comment
64
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:64:86
status:
NEW
view ABCC7 p.Arg347Asp details
We compared [35S]GSH uptake by vesicles containing either phosphorylated wild-type or
R347D
CFTR proteins in the presence of 1 mM GSH, as this concentration is close to the Km(GSH) and is known not to have any non-speci®c effects on non-pore regions of CFTR.
Login to comment
88
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:88:120
status:
NEW
view ABCC7 p.Arg347Asp details
In the current study, we found that [35S]GSH uptake was signi®cantly decreased in membrane vesicles expressing the
R347D
mutant protein, relative to those expressing wild-type CFTR, with rates of GSH ¯ux of 207 and 498 pmol/mg CFTR/h, respectively (Figure 3A; P < 0.0001).
Login to comment
91
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:91:49
status:
NEW
view ABCC7 p.Arg347Asp details
Kinetic analyses revealed that vesicles with the
R347D
mutation exhibited an ~75% decrease in the Vmax of GSH uptake compared with vesicles with wild-type CFTR, corresponding to 176 and 612 pmol GSH/mg CFTR/h, respectively (Table I).
Login to comment
92
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:92:70
status:
NEW
view ABCC7 p.Arg347Asp details
These analyses also suggest that GSH interaction with the pore of the
R347D
mutant is ~4 times stronger than that with the wild-type pore, with Km(GSH) values of 0.11 and 0.47 mM, respectively.
Login to comment
93
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:93:140
status:
NEW
view ABCC7 p.Arg347Asp details
Modi®ed af®nity of GSH for the mutant channel is consistent with previous reports, suggesting altered interaction of GSH with the
R347D
pore (Kogan et al., 2001).
Login to comment
94
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:94:206
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:94:196
status:
NEW
view ABCC7 p.Lys464Ala details
To assess the nucleotide dependence of GSH permeation through CFTR, we determined the consequences of lysine mutations in the conserved Walker A consensus motifs for ATP binding in NBD1 and NBD2:
K464A
and
K1250A
, respectively.
Login to comment
96
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:96:45
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:96:35
status:
NEW
view ABCC7 p.Lys464Ala details
In Figure 4, we show that both the
K464A
and
K1250A
mutants exhibit similar signi®cant reductions in GSH ¯ux.
Login to comment
97
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:97:50
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:97:40
status:
NEW
view ABCC7 p.Lys464Ala details
We observed that GSH uptake in both the
K464A
and
K1250A
membrane vesicles was 3to 4-fold lower than in vesicles expressing wild-type CFTR protein, yielding permeability values of 132 and 120 pmol/mg CFTR/h, respectively (P < 0.001).
Login to comment
100
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:100:101
status:
NEW
view ABCC7 p.Arg347Asp details
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:100:171
status:
NEW
view ABCC7 p.Arg347Asp details
Kinetic parameters of GSH uptake by Sf9 membrane vesicles containing PKA-phosphorylated wild-type or
R347D
CFTR proteins, in the presence of MgAMP-PNP Variables Wild type
R347D
Vmax (pmol/mg CFTR/h) 612 176 Km (mM) 0.47 0.11 Fig. 4.
Login to comment
102
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:102:64
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:102:55
status:
NEW
view ABCC7 p.Lys464Ala details
Membrane vesicles expressing phosphorylated wild-type,
K464A
or
K1250A
CFTR were incubated with 20 nM [35S]GSH and 1 mM cold GSH in CFTR transport buffer, in the presence of MgAMPPNP.
Login to comment
104
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:104:63
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:104:53
status:
NEW
view ABCC7 p.Lys464Ala details
Values shown represent the mean activity (T SEM; for
K464A
and
K1250A
, n = 4; for wild-type CFTR, n = 5).
Login to comment
105
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:105:91
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:105:82
status:
NEW
view ABCC7 p.Lys464Ala details
Inset: expression of CFTR in membranes from Sf9 cells transfected with wild-type,
K464A
or
K1250A
CFTR constructs.
Login to comment
108
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:108:57
status:
NEW
view ABCC7 p.Arg347Asp details
Comparison of GSH ¯ux by wild-type CFTR versus CFTR
R347D
protein.
Login to comment
109
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:109:61
status:
NEW
view ABCC7 p.Arg347Asp details
(A) Membrane vesicles expressing phosphorylated wild-type or
R347D
CFTR proteins were incubated with 20 nM [35S]GSH and 1 mM cold GSH, in the presence of MgAMP-PNP.
Login to comment
111
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:111:76
status:
NEW
view ABCC7 p.Arg347Asp details
Values are expressed as the mean T SEM (n = 5 for wild-type CFTR, n = 2 for
R347D
).
Login to comment
112
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:112:84
status:
NEW
view ABCC7 p.Arg347Asp details
Inset: expression of CFTR in membranes from Sf9 cells transfected with wild-type or
R347D
CFTR constructs.
Login to comment
115
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:115:128
status:
NEW
view ABCC7 p.Arg347Asp details
(B) Effect of increasing substrate concentration on [35S]GSH uptake by vesicles expressing phosphorylated wild-type CFTR or the
R347D
variant, in the presence of MgAMP-PNP.
Login to comment
117
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:117:43
status:
NEW
view ABCC7 p.Arg347Asp details
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:117:171
status:
NEW
view ABCC7 p.Arg347Asp details
[35S]GSH uptake by vesicles expressing the
R347D
protein was also obtained by subtracting GSH uptake values of vesicles with no CFTR from those of vesicles expressing the
R347D
variant.
Login to comment
118
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:118:159
status:
NEW
view ABCC7 p.Arg347Asp details
Curve ®tting was performed by non-linear regression analysis, using the Michaelis±Menten equation, to yield the following kinetic parameters for the
R347D
mutant: Km = 0.11 mM, Vmax = 176 pmol GSH/mg CFTR/h, r2 = 0.97.
Login to comment
194
ABCC7 p.Arg347Asp
X
ABCC7 p.Arg347Asp 12727866:194:97
status:
NEW
view ABCC7 p.Arg347Asp details
ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 12727866:194:111
status:
NEW
view ABCC7 p.Lys1250Ala details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 12727866:194:104
status:
NEW
view ABCC7 p.Lys464Ala details
An Sf9 cell pellet (0.5 l) expressing either recombinant CFTR-His proteins (wild type or mutant:
R347D
,
K464A
,
K1250A
) or no CFTR was solubilized in 30 ml of homogenization buffer containing 250 mM sucrose, 50 mM Tris±HCl, 0.25 mM CaCl2 pH 7.5 and protease inhibitors (Roche Diagnostics GmbH, Mannheim, Germany).
Login to comment